A simple diagnostic test to detect tuberculosis in humans

May 29, 2015
Credit: Fulton Design/123rf.com

Tuberculosis (TB) represents a growing worldwide healthcare burden. Second only to HIV in terms of its global impact, TB infected 8.5 million people and caused 1.4 million deaths in 2011. If these statistics are to improve, early detection is critical.

Led by Taha Roodbar Shojaei and Mohamad Amran Mohd Salleh of Universiti Putra Malaysia, the international research team set out to develop a sensitive new system that could quickly and reliably detect TB in humans. One of their biggest hurdles was to differentiate people infected with tuberculosis from those who have received the bacillus Calmette-Guerin (BCG) vaccine for .

Using modified , and single strand DNAs, the team developed a layered biosensor that not only detects TB in patients' sputum but also differentiates positive results from samples of vaccinated people. Using the new sensor, the team has conducted preliminary tests on 50 clinical samples from patients in Tehran who were suspected of having TB. While current TB diagnostic tests based on the technique for isolating DNA have an approximately 80% success rate for both sensitivity (the ability to correctly identify the disease) and specificity (the ability to rule out other conditions such as BCG vaccination), the new method was rated between 86.6% and 94.2% accurate.

The researchers believe they have developed a simple, rapid, sensitive and specific detection method with an affordable cost. Their biosensor requires small amounts of sputum and could therefore be an appropriate detection technique where limited sample volumes are available.

In 2015, the team plans to further enhance its biosensor system with carbon nanoparticles instead of gold. If time permits, the team will develop a working device and interface to simplify the detection of TB, perhaps with a smartphone app.

Explore further: The true burden of tuberculosis

Related Stories

The true burden of tuberculosis

May 19, 2015
Prisons are common settings for tuberculosis (TB) outbreaks, yet screening and prevention services can be extremely limited. As the spread of drug-resistant TB increases, understanding and monitoring levels of the disease ...

New online tool to predict genetic resistance to tuberculosis drugs

May 27, 2015
Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be can sped up by days or weeks, thanks to a new free online tool.

Blood-based biomarkers could enable simple, accurate TB tests for diagnosis and monitoring

March 30, 2015
Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure.

BCG vaccine more effective than previously thought

December 19, 2013
The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.

Texas hospital TB probe ends with no active cases seen

March 19, 2015
Health officials say they found no active tuberculosis cases among infants possibly exposed to a TB-infected El Paso hospital worker.

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.